RSS   Newsletter   Contact   Advertise with us
Post Online Media

Lantheus Holdings appoints Julie McHugh as director

Lantheus HoldingsLantheus Holdings, parent company of Lantheus Medical Imaging, announced the appointment of Julie McHugh as a member of its board of directors, effective January 25, 2017.
Article continues below

READ MORE Endo COO steps down

Ms. McHugh, who will serve as a member of the Compensation Committee of the Board, brings over 30 years of experience in the pharmaceutical, biotech and medical devices industries.

Ms. McHugh recently served as Chief Operating Officer of Endo Health Solutions, Inc., where she was responsible for the specialty pharmaceutical and generic drug businesses.

Prior to that, Ms. McHugh was CEO of Nora Therapeutics, Inc., a venture capital backed biotech start-up company focused on developing novel therapies for the treatment of infertility disorders.

Previously, she served as Company Group Chairman for Johnson & Johnson's worldwide virology business unit, and prior to that, she was President of Centocor, Inc., a J&J subsidiary.

Ms. McHugh currently serves on the Board of Directors of Aerie Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., New Xellia Group A/S and Trevena Pharmaceuticals, Inc.

Ms. McHugh previously served on the Board of Directors of the Biotechnology Industry Organization, the New England Healthcare Institute, the Pennsylvania Biotechnology Association, EPIRUS Pharmaceuticals, Inc. and ViroPharma Inc.

She received a Master of Business Administration from St. Joseph's University and a Bachelor of Science from Pennsylvania State University.

 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy